LY-2510924 | Interleukin Related interleukin-related.com

Product Name :
LY-2510924

Search keywords :
LY2510924

drugId :
null

Target Vo:
C-X-C motif chemokine receptor 4

Target Vo Short Name :
CXCR4

Moa_Name:
C-X-C motif chemokine receptor 4 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Eli Lilly And Company

Active Indication_Name:
Leukemia

In Active Indication_Name:
Carcinoma, Renal Cell

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RUNX2 Rabbit mAb web
TriMethyl-Histone H3 (Lys27) Rabbit mAb supplier
4E BP1 Antibody: 4E BP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 13 kDa, targeting to 4E BP1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.

Author: Interleukin Related

Related Posts